The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors
Open accessAbstract
Mice unable to synthesize norepinephrine (NE) and epinephrine due to targeted disruption of the dopamine β-hydroxylase gene, Dbh , were used to critically test roles for NE in mediating acute behavioral changes elicited by different classes of antidepressants. To this end, we used the tail suspension test, one of the most widely used paradigms for assessing antidepressant activity and depression-related behaviors in normal and genetically modified mice. Dbh –/– mice failed to respond to the behavioral effects of various antidepressants, including the NE reuptake inhibitors desipramine and reboxetine, the monoamine oxidase inhibitor pargyline, and the atypical antidepressant bupropion, even though they did not differ in baseline immobility from Dbh +/– mice, which have normal levels of NE. Surprisingly, the effects of the selective serotonin reuptake inhibitors (SSRIs) fluoxetine, sertraline, and paroxetine were also absent or severely attenuated in the Dbh –/– mice. In contrast, citalopram (the most selective SSRI) was equally effective at reducing immobility in mice with and without NE. Restoration of NE by using l - threo -3,4-dihydroxyphenylserine reinstated the behavioral effects of both desipramine and paroxetine in Dbh –/– mice, thus demonstrating that the reduced sensitivity to antidepressants is related to NE function, as opposed to developmental abnormalities resulting from chronic NE deficiency. Microdialysis studies demonstrated that the ability of fluoxetine to increase hippocampal serotonin was blocked in Dbh –/– mice, whereas citalopram's effect was only partially attenuated. These data show that NE plays an important role in mediating acute behavioral and neurochemical actions of many antidepressants, including most SSRIs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Self-citationGILBERT, P., & ALLAN, S. (1998) · Psychological Medicine · doi:10.1017/s0033291798006710 · Cited by 972
Bupropion: a review of its mechanism of antidepressant activity.
Ascher, J. A., Cole, J. O., Colin, J. N., Feighner, J. P., Ferris, R. M., Fibiger, H. C., Golden, R. N., Martin, P., Potter, W. Z., & Richelson, E. (1995) · PubMed · Cited by 680
Cryan, J. F., & Mombereau, C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001457 · Cited by 616
Self-citationStahl, S. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0103 · Cited by 489
Noradrenaline is essential for mouse fetal development
Thomas, S. A., Matsumoto, A. M., & Palmiter, R. D. (1995) · Nature · doi:10.1038/374643a0 · Cited by 462
Self-citationSuppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists
Baraban, J. M., & Aghajanian, G. K. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90187-2 · Cited by 440
Sánchez, C., & Hyttel, J. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006986824213 · Cited by 429
Page, M. E., Detke, M. J., Dalvi, A., Kirby, L. G., & Lucki, I. (1999) · Psychopharmacology · doi:10.1007/s002130051156 · Cited by 385
Self-citationReboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
Wong, E. H. F., Sonders, M. S., Amara, S. G., Tinholt, P. M., Piercey, M. F. P., Hoffmann, W. P., Hyslop, D. K., Franklin, S., Porsolt, R. D., Bonsignori, A., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00291-7 · Cited by 334
Bymaster, F. P., Zhang, W., Carter, P. A., Shaw, J., Chernet, E., Phebus, L., Wong, D. T., & Perry, K. W. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0986-x · Cited by 334
Buck, K. J., & Amara, S. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12584 · Cited by 236
Structural and functional brain changes in posttraumatic stress disorder.
Nutt, D., & Malizia, A. L. (2004) · PubMed · Cited by 215
Restoration of Norepinephrine and Reversal of Phenotypes in Mice Lacking Dopamine β‐Hydroxylase
Thomas, S. A., Marck, B. T., Palmiter, R. D., & Matsumoto, A. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062468.x · Cited by 186
Self-citationCryan, J. F., Page, M. E., & Lucki, I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01628-4 · Cited by 185
Self-citationCooper, B. R., Wang, C. M., Cox, R. F., Norton, R., Shea, V., & Ferris, R. M. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.43 · Cited by 184
Impaired Maternal Behavior in Mice Lacking Norepinephrine and Epinephrine
Thomas, S. A., & Palmiter, R. D. (1997) · Cell · doi:10.1016/s0092-8674(00)80446-8 · Cited by 167
Self-citationRedrobe, J. P., Bourin, M., Colombel, M. C., & Baker, G. B. (1998) · Psychopharmacology · doi:10.1007/s002130050638 · Cited by 163
Millan, M. J., Gobert, A., Lejeune, F., Newman‐Tancredi, A., Rivet, J., Auclair, A., & Péglion, J.-L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29415-5 · Cited by 162
Central noradrenergic neurones and stress
Stanford, S. C. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02010-1 · Cited by 153
Treatment strategies for chronic and refractory obsessive-compulsive disorder.
Rasmussen, S. A., & Eisen, J. L. (1997) · PubMed · Cited by 138
Cryan, J. F., Dalvi, A., Jin, S., Hirsch, B. R., Lucki, I., & THOMAS, S. A. (2001) · PubMed · Cited by 129
Self-citationAbercrombie, E. D., & Zigmond, M. J. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-11-04062.1989 · Cited by 125
Valentino, R. J., Curtis, A. L., Page, M. E., Pavcovich, L. A., & Florin-Lechner, S. M. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60863-7 · Cited by 120
Self-citationBeyer, C. E., Boikess, S., Luo, B., & Dawson, L. A. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600403 · Cited by 114
THOMAS, S. A., & Palmiter, R. D. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.3.579 · Cited by 108
Self-citationStanford, S. C. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)81591-4 · Cited by 93
Bortolozzi, A. A., & Artigas, F. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300061 · Cited by 92
Blier, P. (2001) · PubMed · Cited by 89
Knobelman, D. A., Hen, R., & Lucki, I. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29477-5 · Cited by 84
Self-citationHajós‐Korcsok, É., McTavish, S. F. B., & Sharp, T. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00723-8 · Cited by 72
The enhancement of social functioning as a therapeutic principle in the management of depression.
Healy, D., & McMonagle, T. (1997) · PubMed · Cited by 71
Lucki, I., & O'Leary, O. F. (2004) · PubMed · Cited by 70
Self-citationFrazer, A. (1997) · PubMed · Cited by 70
Paroxetine binding to the rat norepinephrine transporter in vivo
Owens, M. J., Knight, D. L., & Nemeroff, C. B. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00314-5 · Cited by 63
Cervo, L., Grignaschi, G., Rossi, C., & Samanin, R. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90433-q · Cited by 60
Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo
Weinshenker, D., White, S. S., Javors, M. A., Palmiter, R. D., & Szot, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02889-5 · Cited by 52
Thomas, D. N., Nutt, D., & Holman, R. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200406 · Cited by 50
Dong, J.-M., & Blier, P. (2001) · Psychopharmacology · doi:10.1007/s002130000665 · Cited by 48
Rénéric, J.-P., Bouvard, M. P., & Stinus, L. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00007-x · Cited by 41
Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex
Hughes, Z. A., & Stanford, S. C. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00715-7 · Cited by 35
Hughes, Z. A., & Stanford, S. C. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701947 · Cited by 34
Kostowski, W. (1986) · PubMed · Cited by 33
Genetic Comparison of Seizure Control by Norepinephrine and Neuropeptide Y
Weinshenker, D., Szot, P., Miller, N. S., Rust, N. C., Hohmann, J. G., Pyati, U. J., White, S. S., & Palmiter, R. D. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07764.2001 · Cited by 30
Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo
Fuller, R. W., Hemrick-Luecke, S. K., Littlefield, E. S., & Audia, J. E. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00110-4 · Cited by 29
Preclinical Pharmacology of Citalopram
Popik, P. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910001-00002 · Cited by 29
Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex
Nakayama, K. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-001-0497-7 · Cited by 27
Soubrié, P., Martin, P., Mestikawy, S. E., & Hamon, M. (1987) · Brain Research · doi:10.1016/0006-8993(87)91646-5 · Cited by 27
Cited by
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Self-citationReconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579
“Rats treated with bupropion demonstrate decreased immobility time during the forced swim test and tail suspension tests (Cryan et al., 2001; Cryan et al., 2004) and showed greater willingness to work for food rewards during a progressive ratio task (Bruijnzeel and Markou, 2003).”
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Self-citationCryan, J. F., Valentino, R. J., & Lucki, I. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.008 · Cited by 1,119
Self-citationThe Forced Swim Test as a Model of Depressive-like Behavior
Yankelevitch-Yahav, R., Franko, M., Huly, A., & Doron, R. (2015) · Journal of Visualized Experiments · doi:10.3791/52587 · Cited by 754
Metadata
- Authors
- Cryan, J. F., O'Leary, O. F., Jin, S.-H., Friedland, J. C., Ouyang, M., Hirsch, B. R., Page, M. E., Dalvi, A., Thomas, S. A., & Lucki, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-05-17
- Volume
- 101
- Issue
- 21
- Pages
- 8186-8191
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2113457968
- Cited by
- 252
- References
- 49
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.